carbamazepine has been researched along with Polycystic Ovarian Syndrome in 11 studies
Carbamazepine: A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties.
carbamazepine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine carrying a carbamoyl substituent at the azepine nitrogen, used as an anticonvulsant.
Excerpt | Relevance | Reference |
---|---|---|
"The study is aimed at comparing effects of older drugs like carbamazepine (CBZ) and newer agent like levetiracetam (LEV) on polycystic ovarian syndrome (PCOS) in women with epilepsy (WWE)." | 8.02 | Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy. ( Alabi, A; Makanjuola, A; Oboh, D; Ogunjimi, L; Ogunniyi, A; Olawale, O; Olusola-Bello, M; Osalusi, B; Yaria, J, 2021) |
"The aim of the study was to compare the effects of carbamazepine (CBZ) and oxcarbazepine (OXC) on the reproductive endocrine function in women with epilepsy." | 7.73 | Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. ( Isojärvi, JI; Koivunen, R; Löfgren, E; Pakarinen, A; Tapanainen, JS, 2006) |
"In order to investigate the possible role of valproic acid therapy in the development of obesity, hyperinsulinism and polycystic ovaries (PCOs), we have studied metabolic parameters and ovarian morphology in epileptic women." | 7.71 | Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. ( Abraham, I; Alge, A; Bauer, G; Haslinger, M; Lechleitner, M; Luef, G; Seppi, K; Trinka, E; Unterberger, I; Windisch, J, 2002) |
"The study is aimed at comparing effects of older drugs like carbamazepine (CBZ) and newer agent like levetiracetam (LEV) on polycystic ovarian syndrome (PCOS) in women with epilepsy (WWE)." | 4.02 | Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy. ( Alabi, A; Makanjuola, A; Oboh, D; Ogunjimi, L; Ogunniyi, A; Olawale, O; Olusola-Bello, M; Osalusi, B; Yaria, J, 2021) |
"The aim of the study was to compare the effects of carbamazepine (CBZ) and oxcarbazepine (OXC) on the reproductive endocrine function in women with epilepsy." | 3.73 | Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy. ( Isojärvi, JI; Koivunen, R; Löfgren, E; Pakarinen, A; Tapanainen, JS, 2006) |
"A group of 105 women (54 of whom were, and had only ever been, taking valproate for at least a year, and 51 who had only ever taken either lamotrigine or carbamazepine, for at least a year) were compared with a group of 50 women who did not have epilepsy: any oral contraceptive taken at the time of testing was recorded and blood levels of follicle stimulating hormone (FSH), luteinising hormone (LH), testosterone and prolactin were estimated from days 2 to 6 of the menstrual cycle (day 1 being the first day of bleeding) and an MRI scan made of their pelvis." | 3.72 | A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy. ( Betts, T; Dutton, N; Greenhill, L; Rolfe, T; Yarrow, H, 2003) |
" Anthropometric measurements, staging of pubertal maturation, and clinical manifestations of hyperandrogenism were assessed, as well as measurement of serum levels of testosterone, dehydroepiandrosterone sulfate (DHEAS), sex hormone-binding globulin (SHBG), and free androgen index (FAI)." | 3.72 | Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy. ( Abd El-Basset, FZ; El Barbary, NS; El-Khayat, HA; Hakky, SM; Mohamed, MS; Nassef, NM; Tohamy, SM; Tomoum, HY; Zaky, AA, 2004) |
"In order to investigate the possible role of valproic acid therapy in the development of obesity, hyperinsulinism and polycystic ovaries (PCOs), we have studied metabolic parameters and ovarian morphology in epileptic women." | 3.71 | Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women. ( Abraham, I; Alge, A; Bauer, G; Haslinger, M; Lechleitner, M; Luef, G; Seppi, K; Trinka, E; Unterberger, I; Windisch, J, 2002) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (18.18) | 18.2507 |
2000's | 8 (72.73) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Ogunjimi, L | 1 |
Yaria, J | 1 |
Makanjuola, A | 1 |
Alabi, A | 1 |
Osalusi, B | 1 |
Oboh, D | 1 |
Olusola-Bello, M | 1 |
Olawale, O | 1 |
Ogunniyi, A | 1 |
Luef, G | 1 |
Abraham, I | 1 |
Haslinger, M | 1 |
Trinka, E | 1 |
Seppi, K | 1 |
Unterberger, I | 1 |
Alge, A | 1 |
Windisch, J | 1 |
Lechleitner, M | 1 |
Bauer, G | 1 |
Betts, T | 1 |
Yarrow, H | 1 |
Dutton, N | 1 |
Greenhill, L | 1 |
Rolfe, T | 1 |
El-Khayat, HA | 1 |
Abd El-Basset, FZ | 1 |
Tomoum, HY | 1 |
Tohamy, SM | 1 |
Zaky, AA | 1 |
Mohamed, MS | 1 |
Hakky, SM | 1 |
El Barbary, NS | 1 |
Nassef, NM | 1 |
Karlov, VA | 1 |
Flück, CE | 1 |
Yaworsky, DC | 1 |
Miller, WL | 1 |
Löfgren, E | 1 |
Tapanainen, JS | 2 |
Koivunen, R | 2 |
Pakarinen, A | 1 |
Isojärvi, JI | 4 |
Laatikainen, TJ | 2 |
Pakarinen, AJ | 3 |
Juntunen, KT | 2 |
Myllylä, VV | 2 |
Knip, M | 2 |
Bauer, J | 1 |
Jarre, A | 1 |
Klingmüller, D | 1 |
Elger, CE | 1 |
Taubøll, E | 1 |
van Parys, J | 1 |
Rättyä, J | 1 |
Harbo, HF | 1 |
Dale, PO | 1 |
Fauser, BC | 1 |
Gjerstad, L | 1 |
1 review available for carbamazepine and Polycystic Ovarian Syndrome
Article | Year |
---|---|
[Therapy of epilepsy: current strategy and tactics].
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Age Factors; Anticonvulsants; Carbamazepine; Child; | 2004 |
10 other studies available for carbamazepine and Polycystic Ovarian Syndrome
Article | Year |
---|---|
Polycystic ovarian syndrome in Nigerian women with epilepsy on carbamazepine/levetiracetam monotherapy.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Levetiracetam; Nigeria; Polycystic | 2021 |
Polycystic ovaries, obesity and insulin resistance in women with epilepsy. A comparative study of carbamazepine and valproic acid in 105 women.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Humans; Insulin Resistance; Obesity; Polycy | 2002 |
A study of anticonvulsant medication on ovarian function in a group of women with epilepsy who have only ever taken one anticonvulsant compared with a group of women without epilepsy.
Topics: Anticonvulsants; Carbamazepine; Case-Control Studies; Epilepsy; Female; Follicle Stimulating Hormone | 2003 |
Physical growth and endocrinal disorders during pubertal maturation in girls with epilepsy.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Dehydroepiandrosterone; Epilepsy; Female; Growth; | 2004 |
Effects of anticonvulsants on human p450c17 (17alpha-hydroxylase/17,20 lyase) and 3beta-hydroxysteroid dehydrogenase type 2.
Topics: 17-Hydroxysteroid Dehydrogenases; Adrenal Cortex Hormones; Androgens; Anticonvulsants; Carbamazepine | 2005 |
Effects of carbamazepine and oxcarbazepine on the reproductive endocrine function in women with epilepsy.
Topics: Adolescent; Adult; Androgens; Androstenedione; Anticonvulsants; Carbamazepine; Comorbidity; Dehydroe | 2006 |
Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy.
Topics: Adolescent; Adult; Analysis of Variance; Carbamazepine; Cross-Sectional Studies; Epilepsies, Partial | 1993 |
Obesity and endocrine disorders in women taking valproate for epilepsy.
Topics: Adult; Body Weight; Carbamazepine; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Endocrine | 1996 |
Polycystic ovary syndrome in patients with focal epilepsy: a study in 93 women.
Topics: Adult; Amenorrhea; Anticonvulsants; Carbamazepine; Cohort Studies; Drug Therapy, Combination; Epilep | 2000 |
Altered ovarian function and cardiovascular risk factors in valproate-treated women.
Topics: Adult; Analysis of Variance; Anticonvulsants; Carbamazepine; Cardiovascular Diseases; Case-Control S | 2001 |